Rethinking MS Therapeutics: From Disease Pathogenesis Mechanisms to AI-Driven Drug Discovery.
Saved in:
| Title: | Rethinking MS Therapeutics: From Disease Pathogenesis Mechanisms to AI-Driven Drug Discovery. |
|---|---|
| Authors: | Ziaei M; Department of Bioinformatics and Systems Biology, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Sehhati M; Department of Bioinformatics and Systems Biology, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Torabi M; Department of Bioinformatics and Systems Biology, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Esmaeil N; Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. n_esmaeil@med.mui.ac.ir., Ghasemi F; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. f_ghasemi@tums.ac.ir. |
| Source: | Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology [J Neuroimmune Pharmacol] 2026 Apr 13; Vol. 21 (1). Date of Electronic Publication: 2026 Apr 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101256586 Publication Model: Electronic Cited Medium: Internet ISSN: 1557-1904 (Electronic) Linking ISSN: 15571890 NLM ISO Abbreviation: J Neuroimmune Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1557-1904 |
|---|---|
| DOI: | 10.1007/s11481-026-10286-x |
